| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | — | -48.9% |
| R&D Expense | $17.7M | — | -6.7% |
| SG&A Expense | $8.1M | — | -2.5% |
| Operating Income | -$26.3M | — | -9.6% |
| Pre-tax Income | -$12.9M | — | +14.6% |
| Income Tax | $84K | — | — |
| Net Income | -$13.0M | — | +14.0% |
| EPS (Basic) | -$0.06 | — | +25.0% |
| EPS (Diluted) | -$0.06 | — | +25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.5M | +45.8% | +7.0% |
| Short-term Investments | $223.9M | -2.3% | +5.9% |
| Accounts Receivable | $4.2M | +95.9% | — |
| Current Assets | $274.7M | +2.7% | +10.2% |
| Total Assets | $554.7M | +21.9% | +32.3% |
| Current Liabilities | $17.1M | +1.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.8M | — | +28.7% |
| Capital Expenditures | $1.7M | — | -29.0% |
| Investing Cash Flow | -$92.3M | — | -402.6% |
| Financing Cash Flow | $120.9M | — | — |
| Free Cash Flow | -$20.4M | — | +28.7% |
| +63.5% |
| Total Liabilities | $29.3M | -24.8% | +31.4% |
| Stockholders' Equity | $525.1M | +26.3% | +32.2% |